Navigation Links
African-American, Caucasian women should take identical vitamin D doses
Date:2/11/2013

Chevy Chase, MD African-American women battling vitamin D deficiencies need the same dose as Caucasian women to treat the condition, according to a recent study accepted for publication in The Endocrine Society's Journal of Clinical Endocrinology & Metabolism (JCEM).

Although women with darker skin tones tend to have lower levels of the biomarker used to measure Vitamin D levels, called 25-hydroxyvitamin D or 25OHD, the study found that older African-American and Caucasian women responded in the same way when they received vitamin D supplements.

Unlike many vitamins that are absorbed primarily from foods, the body's main source of vitamin D is sunlight. Vitamin D deficiency, which is primarily caused by inadequate exposure to sunlight and very poor diet, can result in abnormalities in calcium, phosphorus and bone metabolism. Vitamin D deficiency can cause rickets in children or a bone-softening condition called osteomalacia and muscle weakness in adults.

In a double-blind study that gave varying vitamin D doses to African-American and Caucasian women of similar body size, levels of the 25OHD biomarker were very similar. The findings suggest that vitamin D absorption and metabolism is the same in both groups. Researchers concluded that African-American women tend to have lower levels of the biomarker 25OHD because they naturally produce less vitamin D in the skin after sunlight exposure.

"African-American women don't have to worry about taking larger doses of vitamin D to compensate," said J. Chris Gallagher, MD, of Creighton University School of Medicine in Omaha, Neb., and lead author of the study. "They should follow the current medical guidelines for vitamin D supplementation suggested recently by the Institute of Medicine."

The Endocrine Society has issued a separate set of clinical practice guidelines governing vitamin D dosage. The guidelines are available at http://www.endo-society.org/guidelines/fin
'/>"/>

Contact: Jenni Glenn Gingery
jgingery@endo-society.org
301-941-0240
The Endocrine Society
Source:Eurekalert

Page: 1 2

Related biology news :

1. Cancer risk for African-American women with benign breast disease factors Wayne State finds
2. Few pregnant women treated for sexually transmitted infections
3. Geneviève Almouzni to receive the 2013 FEBS
4. EMBO Women in Science Award
5. Abuse during childhood linked to uterine fibroids in African-American women
6. Women must do more to reap same positive health outcomes as men, MU research suggests
7. Vaginal delivery is the safest option for women with pelvic girdle pain
8. Scientists pinpoint molecular signals that make some women prone to miscarriage
9. Virtual women reveal more skin, regardless of body proportions
10. Overweight pregnant women not getting proper weight-gain advice
11. Abuse during childhood linked to adult-onset asthma in African-American women
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/8/2015)... -- Trovagene, Inc. (NASDAQ: TROV ), a developer of cell-free ... Cancer Monitoring SM platform will be presented at the ... San Diego, CA on June 11-12 , ... Genomics and Cancer Therapy in Salt Lake ... "We continue to advance our clinical programs and present data ...
(Date:6/5/2015)... 5, 2015  Intrexon Corporation ("Intrexon") (NYSE: XON ... it has determined the final distribution ratio relating to ... shares of ZIOPHARM Oncology, Inc. ("ZIOPHARM") (NASDAQ: ZIOP ... the distribution date, as a pro rata dividend on ... purchase shares of Intrexon common stock ("Warrants"), outstanding on ...
(Date:6/1/2015)... June 1, 2015 According to ... Sensing Market by Technology (Touch-based & Touchless), Application (Consumer ... & by Geography - Global Forecast to 2020", published ... is expected to reach $23.55 Billion by 2020, at ... Browse 83 market data T ables ...
Breaking Biology News(10 mins):Clinical Data Featuring Trovagene's Urine-Based Liquid Biopsy Platform to be Presented at Two Upcoming Medical Conferences 2Clinical Data Featuring Trovagene's Urine-Based Liquid Biopsy Platform to be Presented at Two Upcoming Medical Conferences 3Clinical Data Featuring Trovagene's Urine-Based Liquid Biopsy Platform to be Presented at Two Upcoming Medical Conferences 4Intrexon Announces Distribution Ratio for Distribution of ZIOPHARM Shares 2Intrexon Announces Distribution Ratio for Distribution of ZIOPHARM Shares 3Intrexon Announces Distribution Ratio for Distribution of ZIOPHARM Shares 4Gesture Recognition & Touchless Sensing Market Worth $23.55 Billion by 2020 2Gesture Recognition & Touchless Sensing Market Worth $23.55 Billion by 2020 3Gesture Recognition & Touchless Sensing Market Worth $23.55 Billion by 2020 4
... 2011 The risk of deadly hantavirus outbreaks in people ... images to monitor surges in vegetation that boost mouse populations, ... forecast outbreaks of other rodent-borne illnesses worldwide. "It,s a ... out and trap animals all the time," says Denise Dearing, ...
... analysis of sulfur emissions appearing in the journal ... for a decade, worldwide emissions rose again in 2000 ... economy. An accurate read on sulfur emissions will help ... day effects on the atmosphere, health and the environment. ...
... MADISON Recalculating the global use of phosphorous, a fertilizer ... the world,s stocks may soon be in short supply and ... cause of the pollution of lakes, rivers and streams. ... Environmental Research Letters , Stephen Carpenter of the University of ...
Cached Biology News:Monitoring killer mice from space 2Monitoring killer mice from space 3Monitoring killer mice from space 4Monitoring killer mice from space 5Worldwide sulfur emissions rose between 2000-2005, after decade of decline 2Worldwide sulfur emissions rose between 2000-2005, after decade of decline 3Worldwide sulfur emissions rose between 2000-2005, after decade of decline 4World phosphorous use crosses critical threshold 2World phosphorous use crosses critical threshold 3
(Date:7/1/2015)...   Decision Resources Group finds that ... are its oral administration, alternative mechanism of action, ... rheumatologists. Otezla was the first oral therapy specifically ... psoriatic arthritis in the United States ... conventional oral treatments including disease-modifying antirheumatic drugs (DMARDs), ...
(Date:7/1/2015)... Colo. and BANGALORE, India ... global genomic profiling company that uses next generation sequencing ... of Scott A. Storrer as chief executive ... CEO, he will be responsible for all strategy, business ... Chandru , who has served as Strand,s chairman and ...
(Date:7/1/2015)... 1, 2015  Axovant Sciences Ltd. (NYSE:  AXON), ... treatment of dementia, today announced that the company ... at 5:45 p.m. EDT following its presentation of ... Conference 2015 (AAIC). The event ... Dr. Lawrence Friedhoff , Chief Development Officer, ...
(Date:7/1/2015)... (PRWEB) , ... July 01, 2015 , ... A newly ... new ideas to lower the barriers to innovation in life sciences R&D. The Pistoia ... to two cash prizes of US$15,000 and a period of expert mentorship from a ...
Breaking Biology Technology:Surveyed Rheumatologists Report That Otezla's Oral Administration is its Single Greatest Advantage Over Currently Available Treatment Options 2Surveyed Rheumatologists Report That Otezla's Oral Administration is its Single Greatest Advantage Over Currently Available Treatment Options 3Strand Life Sciences Names Scott A. Storrer CEO as Company Continues Global Expansion with Focus on Precision Medicine Product 2Strand Life Sciences Names Scott A. Storrer CEO as Company Continues Global Expansion with Focus on Precision Medicine Product 3Axovant Sciences To Host Investor Briefing And Live Webcast During AAIC 2015 Meeting 2Axovant Sciences To Host Investor Briefing And Live Webcast During AAIC 2015 Meeting 3Pistoia Alliance Launches Startup Challenge 2Pistoia Alliance Launches Startup Challenge 3
... The long-awaited speaking faculty for the September Pharma ... the conference website reports Mark Alexay, President of ... is comprised of 100 speakers from pharmaceutical companies ... in the pipeline. The speaker list may be ...
... of Avastin Will Take Market Share Away from ... New Report from Decision ResourcesWALTHAM, Mass., March 10 ... research and advisory firms for pharmaceutical and healthcare ... in the age-related macular degeneration (AMD) market through ...
... March 10 Christine Lawless, MD, has ... an ACCME-accredited provider of continuing medical education (CME), beginning ... leading authorities in sports medicine cardiology, Dr. Lawless recently ... University Medical Center, where she was Associate Professor ...
Cached Biology Technology:Pharma ChemOutsourcing Unveils 100 Pharma & Biotech Speaker Faculty for 2009 Conference September 14-16 in Long Branch, NJ 2Robust Annual Growth Through 2012 in the Age-Related Macular Degeneration Market Will Be Driven by Expanding Use of Lucentis in Europe 2Robust Annual Growth Through 2012 in the Age-Related Macular Degeneration Market Will Be Driven by Expanding Use of Lucentis in Europe 3Former President of Sports Cardiology Consultants, LLC Christine Lawless, MD, MBA, ABCL, FACC, FACSM, Named Medical Director of CME Enterprise 2
... Fiberboard boxes are ideal for use in refrigerators, freezers, ... racks. Four vibrant colors allow for color coding to ... liquid nitrogen drainage or promote cool air circulation. Supplied ... holds 100 tubes. Box dimensions: 13 x ...
Recombinant Rhesus Monkey IFN-Alpha...
RABBIT ANTI AMPHOTERIN...
GOAT ANTI HUMAN FACTOR 8RELATED ANTIGEN...
Biology Products: